ERYP.PA
Erytech Pharma SA
Price:  
0.50 
EUR
Volume:  
36,364.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ERYP.PA EV/EBITDA

-1497.9%
Upside

As of 2024-12-12, the EV/EBITDA ratio of Erytech Pharma SA (ERYP.PA) is 0.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ERYP.PA's latest enterprise value is -11.85 mil EUR. ERYP.PA's TTM EBITDA according to its financial statements is -23.57 mil EUR. Dividing these 2 quantities gives us the above ERYP.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.0x - 9.1x 8.0x
Forward P/E multiples 9.4x - 10.4x 10.0x
Fair Price (7.34) - (7.08) (6.98)
Upside -1571.9% - -1519.0% -1497.9%
0.50 EUR
Stock Price
(6.98) EUR
Fair Price

ERYP.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA